TKNO

Alpha Teknova Inc. Common Stock (TKNO)

Stock · NASDAQ · Health Care

$7.12as of 8/28/2026

Active signals

Support level
$1.98
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances

About TKNO

Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, res…

Sector
Health Care
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Employees
158

Fundamentals

1-day range
$7.01$7.35
Market cap
$284.15M
P/E (trailing)
P/E (forward)
-37.47
EPS (trailing)
$-0.32
Dividend yield
Beta
0.91
Avg. volume
220.0K
52-week range
$1.91$7.84
Next earnings: November 5, 2026 · EPS estimate $-0.05confirmed

How Alpha Teknova Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$40.52MCost of Revenue$27.08M (67%)SG&A$27.07M (67%)R&D$2.20M (5%)Tax$58.0K (0%)TKNO

Source: 10-K filed Mar 2, 2026 · via SEC EDGAR / Finnhub

Forecasts

5 analyst ratings

Buy 75%
Hold 25%
Sell 0%
1-year price forecast
High
$12
+68.5%
Median
$8
+12.4%
Low
$7
-1.7%

Alpha Teknova Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • TKNO
    Alpha Teknova Inc. Common Stock
    $7.13
    ▼ 2.46%
    Market cap $284.15MP/E
    $1.91$7.84
  • IMDX
    Insight Molecular Diagnostics Inc. Common Stock
    $4.16
    ▼ 3.03%
    Market cap $162.42MP/E
    $2.33$8.51
  • CDIO
    Cardio Diagnostics Holdings Inc. Common stock
    $1.84
    ▼ 1.60%
    Market cap $4.85MP/E
    $0.97$7.91
  • BMRA
    Biomerica Inc. Common Stock
    $2.14
    ▲ 1.67%
    Market cap $4.73MP/E
    $1.45$3.31
  • VRAX
    Virax Biolabs Group Limited Ordinary Shares
    $2.82
    ▼ 4.08%
    Market cap $2.34MP/E
    $2.5$21.75
  • ACHV
    Achieve Life Sciences Inc. Common Shares
    $8.09
    ▼ 1.16%
    Market cap $648.81MP/E
    $2.62$8.61
  • NTLA
    Intellia Therapeutics Inc. Common Stock
    $12.87
    ▼ 1.83%
    Market cap $1.50BP/E
    $7.95$28.25

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions
Acquired
231.0K
Disposed
12.0K

Institutional Ownership

March 31, 2026

Total shares held
7.47M
Total value held
$21.60M
Institutional holders
73
Top holders this quarter
  • Unknown1.88M
  • Unknown1.07M
  • Unknown716.8K
  • Unknown447.1K
  • Unknown441.9K
  • Unknown325.2K
  • Unknown317.1K
  • Unknown307.9K
  • Unknown228.3K
  • Unknown200.0K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.